Top Key Companies for POCT Rapid Diagnostic Reagent Market: F. Hoffman-La Roche Ltd., Guangzhou Wondfo Biotech Co.,Ltd., Thermo Fisher Scientific, Inc., ALDATU BIOSCIENCES, Luminex Corporation, Zhejiang Orient Gene Biotech Co.,Ltd., bioMérieux SA, Danaher, Abbott, Mylab Discovery Solutions Pvt. Ltd., ADT Biotech Sdn Bhd, Quest Diagnostics, Quidel Corporation, Perkin Elmer, Inc., Veredus Laboratories, Hologic Inc., Neuberg Diagnostics.
Global POCT Rapid Diagnostic Reagent Market Research Report: 2023-2030 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global POCT Rapid Diagnostic Reagent Market Overview And Scope:
The Global POCT Rapid Diagnostic Reagent Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of POCT Rapid Diagnostic Reagent utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global POCT Rapid Diagnostic Reagent Market Segmentation
By Type, POCT Rapid Diagnostic Reagent market has been segmented into:
Infectious Disease Detection
Drug Testing
Tumor Marker Detection
Others
By Application, POCT Rapid Diagnostic Reagent market has been segmented into:
Outpatient
Hospitals
Home Care Settings
Others
Regional Analysis of POCT Rapid Diagnostic Reagent Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of POCT Rapid Diagnostic Reagent Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The POCT Rapid Diagnostic Reagent market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the POCT Rapid Diagnostic Reagent market.
Top Key Companies Covered in POCT Rapid Diagnostic Reagent market are:
F. Hoffman-La Roche Ltd.
Guangzhou Wondfo Biotech Co.
Ltd.
Thermo Fisher Scientific
Inc.
ALDATU BIOSCIENCES
Luminex Corporation
Zhejiang Orient Gene Biotech Co.
Ltd.
bioMérieux SA
Danaher
Abbott
Mylab Discovery Solutions Pvt. Ltd.
ADT Biotech Sdn Bhd
Quest Diagnostics
Quidel Corporation
Perkin Elmer
Inc.
Veredus Laboratories
Hologic Inc.
Neuberg Diagnostics
Key Questions answered in the POCT Rapid Diagnostic Reagent Market Report:
1. What is the expected POCT Rapid Diagnostic Reagent Market size during the forecast period, 2022-2028?
2. Which region is the largest market for the POCT Rapid Diagnostic Reagent Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the POCT Rapid Diagnostic Reagent Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the POCT Rapid Diagnostic Reagent Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key POCT Rapid Diagnostic Reagent companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the POCT Rapid Diagnostic Reagent Markets?
7. How is the funding and investment landscape in the POCT Rapid Diagnostic Reagent Market?
8. Which are the leading consortiums and associations in the POCT Rapid Diagnostic Reagent Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: POCT Rapid Diagnostic Reagent Market by Type
5.1 POCT Rapid Diagnostic Reagent Market Overview Snapshot and Growth Engine
5.2 POCT Rapid Diagnostic Reagent Market Overview
5.3 Infectious Disease Detection
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Infectious Disease Detection: Geographic Segmentation
5.4 Drug Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Drug Testing: Geographic Segmentation
5.5 Tumor Marker Detection
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Tumor Marker Detection: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: POCT Rapid Diagnostic Reagent Market by Application
6.1 POCT Rapid Diagnostic Reagent Market Overview Snapshot and Growth Engine
6.2 POCT Rapid Diagnostic Reagent Market Overview
6.3 Outpatient
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Outpatient: Geographic Segmentation
6.4 Hospitals
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals: Geographic Segmentation
6.5 Home Care Settings
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Home Care Settings: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 POCT Rapid Diagnostic Reagent Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 POCT Rapid Diagnostic Reagent Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 POCT Rapid Diagnostic Reagent Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 F. HOFFMAN-LA ROCHE LTD.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 GUANGZHOU WONDFO BIOTECH CO.
7.4 LTD.
7.5 THERMO FISHER SCIENTIFIC
7.6 INC.
7.7 ALDATU BIOSCIENCES
7.8 LUMINEX CORPORATION
7.9 ZHEJIANG ORIENT GENE BIOTECH CO.
7.10 LTD.
7.11 BIOMéRIEUX SA
7.12 DANAHER
7.13 ABBOTT
7.14 MYLAB DISCOVERY SOLUTIONS PVT. LTD.
7.15 ADT BIOTECH SDN BHD
7.16 QUEST DIAGNOSTICS
7.17 QUIDEL CORPORATION
7.18 PERKIN ELMER
7.19 INC.
7.20 VEREDUS LABORATORIES
7.21 HOLOGIC INC.
7.22 NEUBERG DIAGNOSTICS
Chapter 8: Global POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Infectious Disease Detection
8.2.2 Drug Testing
8.2.3 Tumor Marker Detection
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Outpatient
8.3.2 Hospitals
8.3.3 Home Care Settings
8.3.4 Others
Chapter 9: North America POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Infectious Disease Detection
9.4.2 Drug Testing
9.4.3 Tumor Marker Detection
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Outpatient
9.5.2 Hospitals
9.5.3 Home Care Settings
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Infectious Disease Detection
10.4.2 Drug Testing
10.4.3 Tumor Marker Detection
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Outpatient
10.5.2 Hospitals
10.5.3 Home Care Settings
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Infectious Disease Detection
11.4.2 Drug Testing
11.4.3 Tumor Marker Detection
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Outpatient
11.5.2 Hospitals
11.5.3 Home Care Settings
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Infectious Disease Detection
12.4.2 Drug Testing
12.4.3 Tumor Marker Detection
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Outpatient
12.5.2 Hospitals
12.5.3 Home Care Settings
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Infectious Disease Detection
13.4.2 Drug Testing
13.4.3 Tumor Marker Detection
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Outpatient
13.5.2 Hospitals
13.5.3 Home Care Settings
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America POCT Rapid Diagnostic Reagent Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Infectious Disease Detection
14.4.2 Drug Testing
14.4.3 Tumor Marker Detection
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Outpatient
14.5.2 Hospitals
14.5.3 Home Care Settings
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
POCT Rapid Diagnostic Reagent Scope:
Report Data
|
POCT Rapid Diagnostic Reagent Market
|
POCT Rapid Diagnostic Reagent Market Size in 2022
|
USD XXX million
|
POCT Rapid Diagnostic Reagent CAGR 2023 - 2030
|
XX%
|
POCT Rapid Diagnostic Reagent Base Year
|
2022
|
POCT Rapid Diagnostic Reagent Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
F. Hoffman-La Roche Ltd., Guangzhou Wondfo Biotech Co.,Ltd., Thermo Fisher Scientific, Inc., ALDATU BIOSCIENCES, Luminex Corporation, Zhejiang Orient Gene Biotech Co.,Ltd., bioMérieux SA, Danaher, Abbott, Mylab Discovery Solutions Pvt. Ltd., ADT Biotech Sdn Bhd, Quest Diagnostics, Quidel Corporation, Perkin Elmer, Inc., Veredus Laboratories, Hologic Inc., Neuberg Diagnostics.
|
Key Segments
|
By Type
Infectious Disease Detection Drug Testing Tumor Marker Detection Others
By Applications
Outpatient Hospitals Home Care Settings Others
|